CSHL Stories and Media archive for Tag: CSHL Cancer Center

Copper, cancer, and COVID-19: The story of an idea, a meeting, and a paper

3/4/2022

The Copper Cancer Consortium started as a new treatment concept and is now a published paper. Read the story of Banbury's last meeting before COVID. Read the story »

CSHL receives 2021 NCI grant of $4.5 million

10/1/2021

The National Cancer Institute renewed its Basic Laboratory Cancer Center grant for CSHL, marking 34 years of our continued progress in cancer research. Read the story »

Frontiers of cancer research quiz

Test your knowledge of the newest developments in cancer research with some science trivia. Take the quiz »

CSHL organoid facility: Cancer custodians

7/2/2021

To beat our worst enemy, we must first let it grow. Read the story »

Research matters

6/8/2021

Innovative research and educational activities never stopped during the COVID-19 pandemic. Read the story »

Dr. David Tuveson inaugurated as AACR president

4/21/2021

CSHL Cancer Center Director David Tuveson is leading the American Association for Cancer Research. Read the story »

CSHL’s new organoid facility

11/5/2020

The 2,200 square foot facility will make and maintain hundreds of live tissue models grown from patient tumors. Read the story »

New genetic research to understand racial disparity in cancers

9/8/2020

Cold Spring Harbor Laboratory will study the genetic contributions of ethnicity to colon, endometrial, and pancreas cancers in African Americans. Read the story »

Live @ the Lab with David Tuveson: Studying pancreatic cancer

7/29/2020

Cold Spring Harbor Laboratory Cancer Center Director Dave Tuveson presents an exciting new model for studying pancreatic cancer. Watch the video »

The first mouse model of human pancreas cancer subtypes

7/23/2020

CSHL researchers discovered how slow-growing pancreatic tumors can switch into a more deadly sub-type. Read the story »

Applying symptom tracking to COVID-19 outpatient care using famotidine

6/4/2020

Researchers from CSHL and Northwell Health are developing a way to test promising COVID-19 drugs, like famotidine, by tracking outpatient symptoms. Read the story »

David Tuveson named President-Elect of AACR

4/21/2020

CSHL Cancer Center Director David Tuveson has been elected President-Elect of the American Association for Cancer Research. Read the story »

CSHL Cancer Center joins the AACI

1/10/2020

The CSHL Cancer Center becomes the 100th member of the Association of American Cancer Institutes. Read the story »

CSHL wins TD Ready Challenge grant for organoid facility

12/3/2019

CSHL is one of the recipients of the TD Ready Challenge grant to help support the upcoming organoid facility. Read the story »

Milestone reached in new leukemia drug

11/19/2019

Salt-Inducible Kinase 3 (SIK3) could be a good therapeutic candidate for treating MLL translocation positive subtype of leukemia. Read the story »